glp 1 direct to consumer GLP-1s Going Direct, How Novo and Lilly's DTC Strategy is Changing the Game for Patients and Plan Sponsors Direct-to-consumer health company Hims &

It is designed for general weight loss or healthier habits, but does NOT include medical supervision or medication

Davies M, Pieber TR, Hartoft-Nielsen ML, et al

While 96% of employers cover GLP-1s for diabetes, 67% are expanding coverage to include weight management, raising concerns about long-term cost implications for 96% of employers

Tirzepatide for obesity treatment and diabetes prevention

Dipeptidyl peptidase IV inhibition does not adversely affect immune or virological status in HIV infected men and women: a pilot safety study

GLP-1 receptor agonists like semaglutide and tirzepatide work differently: they stimulate insulin secretion, slow gastric emptying, and reduce appetite through central nervous system signaling